Antibodies against Apoptotic Cells Present in End-stage Lung Disease Patients Do Not Correlate with Clinical Outcome after Lung Transplantation

Por Budding, Kevin, van de Graaf, Eduard A., Kardol-Hoefnagel, Tineke, Oudijk, Erik-Jan D., Kwakkel-van Erp, Johanna M., Hack, C. Erik, Otten, Henny G.
Publicado no Front Immunol (2017)

Pretransplant HRCT Characteristics Are Associated with Worse Outcome of Lung Transplantation for Cystic Fibrosis Patients

Por Belle-van Meerkerk, Gerdien, de Jong, Pim A., de Valk, Harold W., Neefjes, Tim, Pameijer, Frank A., Kwakkel-van Erp, Johanna M., van de Graaf, Ed A.
Publicado no PLoS One (2015)

A genetic polymorphism in the CAV1 gene associates with the development of bronchiolitis obliterans syndrome after lung transplantation

Por Kastelijn, Elisabeth A, van Moorsel, Coline HM, Kazemier, Karin M, Roothaan, Suzan M, Ruven, Henk JT, Kwakkel-van Erp, Johanna M, van de Graaf, Ed A, Zanen, Pieter, van Kessel, Diana A, Grutters, Jan C
Publicado em 2011

Soluble CD59 is a Novel Biomarker for the Prediction of Obstructive Chronic Lung Allograft Dysfunction After Lung Transplantation

Por Budding, Kevin, van de Graaf, Eduard. A., Kardol-Hoefnagel, Tineke, Kwakkel-van Erp, Johanna M., Luijk, Bart D., Oudijk, Erik-Jan D., van Kessel, Diana A., Grutters, Jan C., Hack, C. Erik, Otten, Henderikus G.
Publicado no Sci Rep (2016)

The Induction of IgM and IgG Antibodies against HLA or MICA after Lung Transplantation

Por Paantjens, Annelieke W. M., van de Graaf, Ed A., Kwakkel-van Erp, Johanna M., Hoefnagel, Tineke, van Ginkel, Walter G. J., Fakhry, Farzia, van Kessel, Diana A., van den Bosch, Jules M. M., Otten, Henny G.
Publicado em 2011